J&J developing many next-gen vaccines against COVID-19: CEO
It had previously said it was developing a second-generation vaccine that would target the variant first identified in South…
Author
India asks States to manage immunisation drives better
Urges them to avoid wastage of 'elixir-like' COVID-19 vaccines
Moderna commences trial of COVID-19 vaccine in children
The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart in children aged six months to…
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses
Gland Pharma said it would explore more deals for the vaccine
Ocugen intends to sell 100 million doses of COVAXIN in US in 2021
Cracking the US market would be a significant milestone for the company and India’s vaccine industry
No evidence of greater blood clot risk from vaccine: AstraZeneca
Its review covered more than 17 million people vaccinated in the UK and EU and comes after health authorities in some countries…
QUAD pledges to supply billion doses of COVID-19 vaccine across Asia by 2022
The leaders also agreed to set up an experts’ group to help distribute vaccines, as well as working groups on climate change,…
Novavax vaccine shows 96 per cent efficacy against original coronavirus, 86 per cent against UK…
Novavax plans to produce its two-shot vaccine at eight manufacturing locations, including the Serum Institute of India
Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets
Hikma had said in January that it was planning to buy those assets
Vir, GSK to seek EUA for COVID-19 antibody therapy
Vir and GSK also said that a new laboratory study showed the therapy, VIR-7831, was equally effective against the UK, South…